Otom, Antonio, Sr. S.
HRN: 26-48-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/15/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/15/2025
05/21/2025
IV
500 Mg
OD
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes